Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III (vol 12, 686849, 2021)

被引：0

作者：

Huang, Jianhao ^{[1
,2
]}

Shi, Hongyan ^{[1
,3
]}

Song, Muye ^{[1
,4
]}

Liang, Jinan ^{[1
,3
]}

Zhang, Zhiyuan ^{[1
,3
]}

Chen, Xiaohang ^{[1
,2
]}

Liu, Yongchen ^{[1
]}

Wang, Sanming ^{[1
]}

Wu, Zeyu ^{[1
]}

机构：

[1] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Gen Surg, Guangzhou, Peoples R China

[2] Shantou Univ Med Coll, Shantou, Peoples R China

[3] Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China

[4] South China Univ Technol, Sch Med, Guangzhou, Peoples R China

来源：

FRONTIERS IN ENDOCRINOLOGY | 2024年 / 15卷

关键词：

thyroid cancer; autoimmune thyroid antibodies; tumor size; fine needle aspirate (FNA); microcalcification;

D O I：

10.3389/fendo.2024.1517690

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2